Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07872826 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial Evaluating the Efficacy and Safety of Local Infiltration of RF16001 for Injection for Analgesia After Total Hip Arthroplasty in China

StatusEnrolling by Invitation
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
A multicenter, randomized, double-blind, placebo-positive, parallel-controlled, phase Ⅲ clinical trial was conducted to investigate the efficacy and safety of RF16001 local infiltration for analgesia after total hip arthroplasty. The primary objective was to evaluate the effectiveness of local infiltration of RF16001 for injection for postoperative analgesia after total hip arthroplasty. The secondary objective was to evaluate the safety of local infiltration of RF16001 for injection for analgesia after total hip arthroplasty.
Trial Details
NCT Number NCT07872826
Lead Sponsor The Third Xiangya Hospital of Central South University
Collaborators: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province
Conditions
(from sponsor)		 Pain After Abdominal Surgery
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov